Efficacy and tolerability of tirzepatide, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens
CrossRef Cigarette Smoke Contributes to the Progression of MASLD: From the Molecular Mechanisms to Therapy Jiatong Xu, Yifan Li, Zixuan Feng, Hongping Chen Cells .2025
All patients have the opportunity to receive 1-on-1 virtual Care Coaching at no added cost
Tirzepatide expiration dates follow similar ranges
The WW behavioral system is the most battle-tested weight-loss methodology in existence
The main thing to watch for is increased nausea, as both medications can be hard on an empty stomach